Arvinas

Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.

About

Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. The company was founded in 2013 and is headquartered in Connecticut, United States.

Mission

Arvinas is dedicated to revolutionizing the treatment of diseases through its pioneering PROTAC® technology, which harnesses the body's natural protein degradation system to target and eliminate disease-causing proteins. The company's core mission is to develop innovative therapies that address previously untreatable conditions, ultimately improving the lives of patients worldwide. By focusing on breakthrough science and fostering a collaborative work environment, Arvinas aims to lead the charge in creating a new class of transformative medicines for a wide range of diseases, including cancer and neurodegenerative disorders.

Employee Benefits

  • Competitive package of base and incentive compensation
  • Comprehensive benefits program designed to support the health, wellness, and financial security of employees and their families
  • Group medical, vision, and dental coverage
  • Group and supplemental life insurance

Core Values

  • Innovation: Arvinas is dedicated to pushing the boundaries of science and technology, encouraging employees to think outside the box and pursue groundbreaking solutions.
  • Collaboration: Collaboration is key to Arvinas's success, fostering a team-oriented environment that values open communication, mutual respect, and shared decision-making.
  • Integrity: Arvinas operates with the highest ethical standards, prioritizing honesty, transparency, and accountability in all aspects of its business.
  • Diversity and Inclusion: Arvinas is committed to creating a diverse and inclusive workplace, recognizing the value of different perspectives and experiences in driving innovation and success.
  • Passion: Arvinas is driven by a passion for improving human health, inspiring employees to work tirelessly towards this shared goal.

Arvinas

Leadership

President and CEO at Arvinas

John Houston

President and CEO
Vice President of Neuroscience and Platform Biology at Arvinas

Angela M. Cacace

Vice President of Neuroscience and Platform Biology
Vice President at Arvinas

Matthew Batters

Vice President

Open Jobs

No items found.
Location
New Haven, CT
N/A
Company Size
101-250
N/A
Revenue Range
$10M to $50M
N/A
Valuation
N/A
Founded
2013-01-01
N/A
Current Status
IPO
N/A
Work Mode
Open Roles
4
Hiring Now
Hiring now

Funding

Total Funding
$
111600000
Funding Rounds
3
Num Investors
1
Work Mode
IPO Status
Public
Funding Stage
IPO
Last Funding Date
2018-04-04
Last Funding Type
Series C
Hiring Now
Hiring now
Track & Research Arvinas for Your Next Interview
Start Tracking for Free

Want Jobs in Your Inbox?

Sign up for the Teal newsletter and get career guidance and new jobs weekly!
Thank you! Your submission has been received!
Oops! Please provide a correct email address